@prefix this: . @prefix sub: . @prefix drugbank: . @prefix np: . @prefix mondo: . @prefix pav: . @prefix infores: . @prefix xsd: . @prefix ntemplate: . @prefix orcid: . @prefix rdfs: . @prefix pmid: . @prefix ncit: . @prefix rdf: . @prefix biolink: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { drugbank:DB00334 a biolink:Drug; rdfs:label "Olanzapine"; biolink:category biolink:Drug . mondo:0001156 a biolink:Disease; rdfs:label "Borderline personality disorder (disease)"; biolink:category biolink:Disease . sub:association rdf:object mondo:0001156; rdf:predicate biolink:treats; rdf:subject drugbank:DB00334; a biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation; rdfs:label "The SGA olanzapine is considered the most appropriate, followed by quetiapine and aripiprazole. Although off-label prescription of SGAs represents a common clinical practice in accordance with a worldwide trend, the use of long-acting injection formulations was considered inappropriate by 69% of psychiatrists in our sample. Attitudes on off-label use of Olanzapine in the treatment of BPD: Highly inappropriate = 26 (12.9%); Innapropriate = 26 (12.9%); Doubt = 86 (42.5%); Appropriate = 64 (31.7%); Highly appropriate = 0 (0%)"; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation; biolink:has_population_context sub:context; biolink:publications pmid:31609189; biolink:relation ncit:C94303 . sub:context a biolink:Cohort; rdfs:label "Adults"; biolink:category biolink:Cohort . } sub:provenance { sub:assertion prov:wasAttributedTo orcid:0000-0002-7641-6446 . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB"; npx:hasSignature "kSktg4EOTY9WCClLLAmrms9b9HIbsnqaF4WlKYPSsUdGeLhGTH0qFjND5xIp9dD11tyMUfVErOUSW0bfjx1JkCMzOql5Y034aSykkj0zPPh2eZ5b9mQDxtiBlIqpx4kzKXabirXXk7P9tzE1guc2LEFfA+oiFRluXN/Wins+3Pc="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2022-09-16T11:49:20.029707"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-1501-1082; ntemplate:wasCreatedFromTemplate . biolink: pav:version "2.3.0" . }